Ana Martins

Detection of early sub-clinical trastuzumab-induced cardiotoxicity in breast cancer patients.

C. Fonseca, M. Mendes, M. Correia, 2013, Arquivos brasileiros de cardiologia.

ARX788, a novel anti-HER2 antibody-drug conjugate, shows anti-tumor effects in preclinical models of trastuzumab emtansine-resistant HER2-positive breast cancer and gastric cancer.

J. Isola, H. Joensuu, P. Laakkonen, 2020, Cancer letters.

A Novel Anti-HER2 Antibody–Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab Emtansine

J. Isola, H. Joensuu, P. Laakkonen, 2019, Molecular Cancer Therapeutics.

Detection of Early SubClinical Trastuzumab-Induced Cardiotoxicity in Breast Cancer Patients

C. Fonseca, M. Mendes, M. Correia, 2013 .